Human immunodeficiency virus type 1 subtypes differ in disease progression. 1999

P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
Department of Immunology, Harvard School of Public Health, Boston, Massachusetts, USA. pkanki@hsph.harvard.edu

At least 10 different genetic human immunodeficiency virus type 1 (HIV-1) subtypes (A-J) are responsible for the AIDS pandemic. Much of the understanding of HIV-1 disease progression derives from studies in the developed world where HIV infection is almost exclusively subtype B. This has led many to question whether the properties and consequences of HIV-1 infection can be generalized across subtypes that afflict the majority of infected persons in the developing world. From 1985 to 1997, a prospective study of registered female sex workers in Senegal tracked the introduction and spread of HIV-1 subtypes A, C, D, and G. In clinical follow-up, the AIDS-free survival curves differed by HIV-1 subtype. Women infected with a non-A subtype were 8 times more likely to develop AIDS than were those infected with subtype A (hazard ratio=8.23; P=. 009), the predominant subtype in the study. These data suggest that HIV-1 subtypes may differ in rates of progression to AIDS.

UI MeSH Term Description Entries
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011477 Sex Work The act or practice of engaging in sexual relations for money or other benefit. Commercial Sex,Prostitution,Sex Industry,Industries, Sex,Sex Industries,Sex, Commercial,Work, Sex
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012675 Senegal A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar. Republic of Senegal
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
June 1996, The Journal of infectious diseases,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
January 2012, Archives de l'Institut Pasteur de Tunis,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
October 2005, The West Indian medical journal,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
July 1997, The Journal of infectious diseases,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
October 2009, Yonsei medical journal,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
January 2009, Disease markers,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
July 1990, American journal of hematology,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
November 2002, AIDS research and human retroviruses,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
December 1988, Pediatrics,
P J Kanki, and D J Hamel, and J L Sankalé, and C c Hsieh, and I Thior, and F Barin, and S A Woodcock, and A Guèye-Ndiaye, and E Zhang, and M Montano, and T Siby, and R Marlink, and I NDoye, and M E Essex, and S MBoup
January 2013, The Journal of general virology,
Copied contents to your clipboard!